Literature DB >> 18606647

IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.

Javier Ochoa-Repáraz1, Agnieszka Rynda, Miguel A Ascón, Xinghong Yang, Irina Kochetkova, Carol Riccardi, Gayle Callis, Theresa Trunkle, David W Pascual.   

Abstract

Treatment with an anti-inflammatory Salmonella vaccine expressing enterotoxigenic Escherichia coli colonization factor Ag 1 (CFA/I) proved effective in stimulating protective, potent CD25(+)CD4(+) regulatory T (T(reg)) cells in susceptible mice challenged with experimental autoimmune encephalomyelitis (EAE). Because the Salmonella vector was considerably less protective, we questioned whether altering fimbrial subunit expression to resemble conventional Salmonella expression may impact T(reg) cell potency. The Salmonella-CFA/I vaccine was modified to limit fimbrial subunit expression to the intracellular compartment (Salmonella-CFA/I(IC)). SJL mice were challenged with proteolipid protein peptide 139-151 to induce EAE and orally treated with one of three Salmonella vaccines 6 days postchallenge. Treatment with Salmonella-CFA/I(IC) greatly reduced clinical disease, similarly as Salmonella-CFA/I, by subduing IL-17 and IL-21; however, mechanisms of protection differed as evident by increased IL-13 and IFN-gamma but diminished TGF-beta production by T(reg) cells from Salmonella-CFA/I(IC)-treated mice. Adoptive transfer of T(reg) cells from both CFA/I-expressing constructs was equivalent in protecting against EAE, showing minimal disease. Although not as potent in its protection, CD25(-)CD4(+) T cells from Salmonella-CFA/I(IC) showed minimal Th2 cells, but vaccination did prime these Th2 cells rendering partial protection against EAE challenge. In vivo IL-13 but not IFN-gamma neutralization compromised protection conferred by adoptive transfer with Salmonella-CFA/I(IC)-induced T(reg) cells. Thus, the Salmonella-CFA/I(IC) vaccine elicits T(reg) cells with attributes from both the Salmonella vector and Salmonella-CFA/I vaccines. Importantly, these T(reg) cells can be induced to high potency by simply vaccinating against irrelevant Ags, offering a novel approach to treat autoimmune diseases independently of the autoantigen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606647      PMCID: PMC2599928          DOI: 10.4049/jimmunol.181.2.954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Expression of recombinant rat interleukin-13 (IL-13) and generation of a neutralizing rat IL-13 antiserum.

Authors:  F G Lakkis; E N Cruet; G M Nassar; K F Badr; D W Pascual
Journal:  Biochem Biophys Res Commun       Date:  1997-06-27       Impact factor: 3.575

Review 2.  Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.

Authors:  W J Karpus; R M Ransohoff
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

3.  IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

Authors:  D O Willenborg; S Fordham; C C Bernard; W B Cowden; I A Ramshaw
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 4.  Immunology of multiple sclerosis.

Authors:  Mireia Sospedra; Roland Martin
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella.

Authors:  J L VanCott; H F Staats; D W Pascual; M Roberts; S N Chatfield; M Yamamoto; M Coste; P B Carter; H Kiyono; J R McGhee
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

6.  G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice.

Authors:  Deeqa A Mahamed; Annette Marleau; Mawadda Alnaeeli; Bhagirath Singh; Xiaoxia Zhang; Joseph M Penninger; Yen-Tung A Teng
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.

Authors:  S Wu; D W Pascual; J L VanCott; J R McGhee; D R Maneval; M M Levine; D M Hone
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

Authors:  T Takahashi; Y Kuniyasu; M Toda; N Sakaguchi; M Itoh; M Iwata; J Shimizu; S Sakaguchi
Journal:  Int Immunol       Date:  1998-12       Impact factor: 4.823

9.  Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains.

Authors:  T T Duong; F D Finkelman; B Singh; G H Strejan
Journal:  J Neuroimmunol       Date:  1994-08       Impact factor: 3.478

10.  Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses.

Authors:  N Okahashi; M Yamamoto; J L Vancott; S N Chatfield; M Roberts; H Bluethmann; T Hiroi; H Kiyono; J R McGhee
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  35 in total

1.  Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.

Authors:  Gil Benedek; Jun Zhang; Ha Nguyen; Gail Kent; Hilary A Seifert; Sean Davin; Patrick Stauffer; Arthur A Vandenbark; Lisa Karstens; Mark Asquith; Halina Offner
Journal:  J Neuroimmunol       Date:  2017-06-21       Impact factor: 3.478

2.  Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis.

Authors:  Irina Kochetkova; Theresa Thornburg; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

3.  Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Authors:  Agnieszka Rynda-Apple; Eduardo Huarte; Massimo Maddaloni; Gayle Callis; Jerod A Skyberg; David W Pascual
Journal:  Eur J Immunol       Date:  2010-12-29       Impact factor: 5.532

4.  The gut microbiome in multiple sclerosis.

Authors:  Daniel W Mielcarz; Lloyd H Kasper
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

Review 5.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

6.  IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.

Authors:  Subhasis Barik; Jason S Ellis; Jason A Cascio; Mindy M Miller; Tobechukwu K Ukah; Alexis N Cattin-Roy; Habib Zaghouani
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

7.  Assessment of ability of human adipose derived stem cells for long term overexpression of IL-11 and IL-13 as therapeutic cytokines.

Authors:  Asma Eslami; Moein Dehbashi; Mehnoosh Ashja-Arvan; Hossein Salehi; Maryam Azimzadeh; Mazdak Ganjalikhani-Hakemi
Journal:  Cytotechnology       Date:  2020-09-15       Impact factor: 2.058

8.  IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function.

Authors:  Mermagya Dhakal; John C Hardaway; Fatma Betul Guloglu; Mindy M Miller; Christine M Hoeman; Adam A Zaghouani; Xiaoxiao Wan; Linda M Rowland; Jason A Cascio; Michael P Sherman; Habib Zaghouani
Journal:  Eur J Immunol       Date:  2014-01-13       Impact factor: 5.532

9.  MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Hongbing Guan; Daping Fan; Davit Mrelashvili; Haiping Hao; Narendra P Singh; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Eur J Immunol       Date:  2012-11-29       Impact factor: 5.532

10.  IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Authors:  Agnieszka Rynda; Massimo Maddaloni; Javier Ochoa-Repáraz; Gayle Callis; David W Pascual
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.